| scholarly article | Q13442814 |
| P50 | author | Benoit Chassaing | Q56154430 |
| Andrew T Gewirtz | Q100427123 | ||
| P2860 | cites work | Recent Insights Into the Genetics of Inflammatory Bowel Disease | Q22250935 |
| High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease | Q22250942 | ||
| Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci | Q24618592 | ||
| The Altered Schaedler Flora: Continued Applications of a Defined Murine Microbial Community | Q26795708 | ||
| Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 | Q29615053 | ||
| NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis | Q29616155 | ||
| Potential for using a hermetically-sealed, positive-pressured isocage system for studies involving germ-free mice outside a flexible-film isolator | Q30980697 | ||
| Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria | Q33523015 | ||
| Toll-like receptor 9-induced type I IFN protects mice from experimental colitis | Q33683729 | ||
| Spatial distribution and stability of the eight microbial species of the altered schaedler flora in the mouse gastrointestinal tract | Q33707348 | ||
| Proteobacteria-specific IgA regulates maturation of the intestinal microbiota. | Q33728302 | ||
| AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition | Q33872260 | ||
| IBD-what role do Proteobacteria play? | Q34255700 | ||
| Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation | Q34408108 | ||
| Proneness of TLR5 deficient mice to develop colitis is microbiota dependent | Q34480383 | ||
| Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice | Q34619950 | ||
| Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice | Q35026610 | ||
| Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut | Q35044326 | ||
| Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome | Q35570155 | ||
| Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice | Q35829504 | ||
| Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice | Q36087089 | ||
| Deletion of TLR5 results in spontaneous colitis in mice | Q36138027 | ||
| Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses | Q37581953 | ||
| Draft genome sequences of the altered schaedler flora, a defined bacterial community from gnotobiotic mice | Q37697283 | ||
| Diabetes, obesity and gut microbiota | Q38114548 | ||
| Functional properties of flagellin as a stimulator of innate immunity | Q38804686 | ||
| Inflammatory disease caused by intestinal pathobionts | Q39131979 | ||
| A pathobiont of the microbiota balances host colonization and intestinal inflammation. | Q40177229 | ||
| Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation | Q40285255 | ||
| Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium | Q40442598 | ||
| Interleukin-1β (IL-1β) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis. | Q54367125 | ||
| Intestinal Bacterial Colonization Induces Mutualistic Regulatory T Cell Responses | Q60556933 | ||
| Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease | Q62660266 | ||
| The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases | Q84002918 | ||
| Intestinal microflora functions in laboratory mice claimed to harbor a "normal" intestinal microflora. Is the SPF concept running out of date? | Q84777287 | ||
| A simple cage-autonomous method for the maintenance of the barrier status of germ-free mice during experimentation | Q87512039 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0195310 | |
| P577 | publication date | 2018-04-04 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Mice harboring pathobiont-free microbiota do not develop intestinal inflammation that normally results from an innate immune deficiency | |
| P478 | volume | 13 |
Search more.